Literature DB >> 8644721

Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.

E W Clayton1, V L Hannig, J P Pfotenhauer, R A Parker, P W Campbell, J A Phillips.   

Abstract

We used signs and letters to offer free cystic fibrosis (CF) carrier screening to nonpregnant adults in stable relationships who visited numerous clinical and nonclinical sites in Nashville. A total of 179 individuals (<<1% of those eligible) elected to be tested. To understand this observation, we used questionnaires to assess individuals' attitudes about genetic testing in general and about CF carrier screening in particular (n=873). Participants expressed conflicting views about carrier screening. More than 90% of people thought that genetic testing should at least be available. Most respondents said that the views of their partners and physicians were important in their decision making, and most believed that these others favored genetic testing. Yet, more than two-thirds indicated that such factors as insurability, being "at risk," what they would need to learn, abortion, and religious beliefs were important in their decision making, opinions that mitigated against genetic testing. In particular, one-third feared that carriers would lose their health insurance, one-quarter said that they would have been more interested had they been able to provide DNA by buccal swab rather than by finger stick, and less than one-sixth believed that genetic testing was meddling in God's plan. In the face of both the low level of use of free CF carrier screening by nonpregnant couples when it was not offered in person by health-care professionals and the wide variety of concerns demonstrated, we believe that clinicians should not routinely offer carrier screening to nonpregnant individuals who do not have a family history of CF.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1996        PMID: 8644721      PMCID: PMC1914565     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  The cystic fibrosis gene: medical and social implications for heterozygote detection.

Authors:  Benjamin S Wilfond; Norman Fost
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

2.  Screening for cystic fibrosis; public policy and personal choices.

Authors:  H R Colten
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

3.  The American Society of Human Genetics statement on cystic fibrosis screening.

Authors:  C T Caskey; M M Kaback; A L Beaudet
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

4.  Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families.

Authors:  D C Wertz; S R Janes; J M Rosenfield; R W Erbe
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

5.  Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening.

Authors:  R R Faden; E S Tambor; G A Chase; G Geller; K J Hofman; N A Holtzman
Journal:  Am J Med Genet       Date:  1994-03-01

6.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

Authors:  H Bekker; M Modell; G Denniss; A Silver; C Mathew; M Bobrow; T Marteau
Journal:  BMJ       Date:  1993-06-12

7.  Prenatal screening for cystic fibrosis.

Authors:  M E Mennie; A Gilfillan; M Compton; L Curtis; W A Liston; I Pullen; D A Whyte; D J Brock
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

8.  Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.

Authors:  M Kaback; J Lim-Steele; D Dabholkar; D Brown; N Levy; K Zeiger
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

9.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.

Authors:  E S Tambor; B A Bernhardt; G A Chase; R R Faden; G Geller; K J Hofman; N A Holtzman
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

10.  Teaching about cystic fibrosis carrier screening by using written and video information.

Authors:  E W Clayton; V L Hannig; J P Pfotenhauer; R A Parker; P W Campbell; J A Phillips
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

View more
  21 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

2.  Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making.

Authors:  Alison D Archibald; Belinda J McClaren
Journal:  J Community Genet       Date:  2011-11-17

3.  "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare.

Authors:  Alison D Archibald; Chriselle L Hickerton; Samantha A Wake; Alice M Jaques; Jonathan Cohen; Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2016-02-03

4.  The changing landscape of carrier screening: expanding technology and options?.

Authors:  Michelle L McGowan; Deborah Cho; Richard R Sharp
Journal:  Health Matrix Clevel       Date:  2013

5.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

Authors:  W W Grody; C Dunkel-Schetter; Z H Tatsugawa; M A Fox; C Y Fang; R M Cantor; J M Novak; H N Bass; B F Crandall
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

Authors:  Aimee Anido; Lisa M Carlson; Lisa Taft; Stephanie L Sherman
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

7.  God and genes in the caring professions: clinician and clergy perceptions of religion and genetics.

Authors:  Virginia L Bartlett; Rolanda L Johnson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-02-15       Impact factor: 3.908

8.  Religious and spiritual issues in medical genetics.

Authors:  Joseph B Fanning; Ellen Wright Clayton
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-02-15       Impact factor: 3.908

9.  'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening.

Authors:  L Ioannou; J Massie; S Lewis; B McClaren; V Collins; M B Delatycki
Journal:  J Community Genet       Date:  2013-05-29

10.  What do patients prefer: informed consent models for genetic carrier testing.

Authors:  K E Ormond; M Iris; S Banuvar; J Minogue; G J Annas; S Elias
Journal:  J Genet Couns       Date:  2007-05-11       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.